Literature DB >> 25216635

An extracorporeal blood-cleansing device for sepsis therapy.

Joo H Kang1, Michael Super2, Chong Wing Yung3, Ryan M Cooper4, Karel Domansky5, Amanda R Graveline5, Tadanori Mammoto6, Julia B Berthet5, Heather Tobin6, Mark J Cartwright5, Alexander L Watters5, Martin Rottman2, Anna Waterhouse5, Akiko Mammoto6, Nazita Gamini5, Melissa J Rodas5, Anxhela Kole5, Amanda Jiang6, Thomas M Valentin5, Alexander Diaz5, Kazue Takahashi7, Donald E Ingber8.   

Abstract

Here we describe a blood-cleansing device for sepsis therapy inspired by the spleen, which can continuously remove pathogens and toxins from blood without first identifying the infectious agent. Blood flowing from an infected individual is mixed with magnetic nanobeads coated with an engineered human opsonin--mannose-binding lectin (MBL)--that captures a broad range of pathogens and toxins without activating complement factors or coagulation. Magnets pull the opsonin-bound pathogens and toxins from the blood; the cleansed blood is then returned back to the individual. The biospleen efficiently removes multiple Gram-negative and Gram-positive bacteria, fungi and endotoxins from whole human blood flowing through a single biospleen unit at up to 1.25 liters per h in vitro. In rats infected with Staphylococcus aureus or Escherichia coli, the biospleen cleared >90% of bacteria from blood, reduced pathogen and immune cell infiltration in multiple organs and decreased inflammatory cytokine levels. In a model of endotoxemic shock, the biospleen increased survival rates after a 5-h treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25216635     DOI: 10.1038/nm.3640

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  57 in total

1.  Global surveillance of antibiotic resistance.

Authors:  T F O'Brien
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

Review 2.  Extracorporeal organ support following trauma: the dawn of a new era in combat casualty critical care.

Authors:  Lucas P Neff; Jeremy W Cannon; Ian J Stewart; Andriy I Batchinsky; David H Zonies; Jeremy C Pamplin; Kevin K Chung
Journal:  J Trauma Acute Care Surg       Date:  2013-08       Impact factor: 3.313

3.  A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells.

Authors:  Joo H Kang; Silva Krause; Heather Tobin; Akiko Mammoto; Mathumai Kanapathipillai; Donald E Ingber
Journal:  Lab Chip       Date:  2012-03-28       Impact factor: 6.799

4.  A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus.

Authors:  Ian C Michelow; Mingdong Dong; Bruce A Mungall; L Michael Yantosca; Calli Lear; Xin Ji; Marshall Karpel; Christina L Rootes; Matthew Brudner; Gunnar Houen; Damon P Eisen; T Bernard Kinane; Kazue Takahashi; Gregory L Stahl; Gene G Olinger; Gregory T Spear; R Alan B Ezekowitz; Emmett V Schmidt
Journal:  J Biol Chem       Date:  2010-06-01       Impact factor: 5.157

5.  Nucleic acid is a novel ligand for innate, immune pattern recognition collectins surfactant proteins A and D and mannose-binding lectin.

Authors:  Nades Palaniyar; Jeya Nadesalingam; Howard Clark; Michael J Shih; Alister W Dodds; Kenneth B M Reid
Journal:  J Biol Chem       Date:  2004-05-15       Impact factor: 5.157

Review 6.  The pathogenesis of sepsis.

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

7.  Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals.

Authors:  A B Onderdonk; W M Weinstein; N M Sullivan; J G Bartlett; S L Gorbach
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

Review 8.  Drotrecogin alfa (activated)...a sad final fizzle to a roller-coaster party.

Authors:  Derek C Angus
Journal:  Crit Care       Date:  2012-02-06       Impact factor: 9.097

9.  Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis.

Authors:  Jose Garnacho-Montero; Teresa Aldabo-Pallas; Carmen Garnacho-Montero; Aurelio Cayuela; Rocio Jiménez; Sonia Barroso; Carlos Ortiz-Leyba
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 10.  Mannose-binding lectin in innate immunity: past, present and future.

Authors:  R M Dommett; N Klein; M W Turner
Journal:  Tissue Antigens       Date:  2006-09
View more
  73 in total

Review 1.  Immune therapy in sepsis: Are we ready to try again?

Authors:  Roger Davies; Kieran O'Dea; Anthony Gordon
Journal:  J Intensive Care Soc       Date:  2018-04-04

Review 2.  Synthetic biology devices for in vitro and in vivo diagnostics.

Authors:  Shimyn Slomovic; Keith Pardee; James J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-24       Impact factor: 11.205

Review 3.  Recent Developments in Magnetic Diagnostic Systems.

Authors:  Hakho Lee; Tae-Hyun Shin; Jinwoo Cheon; Ralph Weissleder
Journal:  Chem Rev       Date:  2015-08-10       Impact factor: 60.622

4.  Self-assembling peptides for stem cell and tissue engineering.

Authors:  Philip D Tatman; Ethan G Muhonen; Sean T Wickers; Albert O Gee; Eung-Sam Kim; Deok-Ho Kim
Journal:  Biomater Sci       Date:  2016-02-15       Impact factor: 6.843

Review 5.  Rapid separation of bacteria from blood-review and outlook.

Authors:  William G Pitt; Mahsa Alizadeh; Ghaleb A Husseini; Daniel S McClellan; Clara M Buchanan; Colin G Bledsoe; Richard A Robison; Rae Blanco; Beverly L Roeder; Madison Melville; Alex K Hunter
Journal:  Biotechnol Prog       Date:  2016-06-03

6.  Light-controlled active release of photocaged ciprofloxacin for lipopolysaccharide-targeted drug delivery using dendrimer conjugates.

Authors:  Pamela T Wong; Shengzhuang Tang; Jhindan Mukherjee; Kenny Tang; Kristina Gam; Danielle Isham; Claire Murat; Rachel Sun; James R Baker; Seok Ki Choi
Journal:  Chem Commun (Camb)       Date:  2016-08-16       Impact factor: 6.222

7.  FcRγ deficiency improves survival in experimental sepsis by down-regulating TLR4 signaling pathway.

Authors:  Zhi-Min Wei; Zhuo Wang; Xiao-Jian Wan; Xian-Jing Li; Yi-Xing Li; Yang Bai; Xue Yang; Yong Yang; Shun-Chang Jiao; Zhe-Feng Liu
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

Review 8.  Recent advances in nanomedicine for sepsis treatment.

Authors:  Simseok A Yuk; Diego A Sanchez-Rodriguez; Michael D Tsifansky; Yoon Yeo
Journal:  Ther Deliv       Date:  2018-05-01

Review 9.  The immunopathology of sepsis and potential therapeutic targets.

Authors:  Tom van der Poll; Frank L van de Veerdonk; Brendon P Scicluna; Mihai G Netea
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

10.  Emerging Microtechnologies and Automated Systems for Rapid Bacterial Identification and Antibiotic Susceptibility Testing.

Authors:  Yiyan Li; Xing Yang; Weian Zhao
Journal:  SLAS Technol       Date:  2017-08-29       Impact factor: 3.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.